Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain
· Delayed Price · Currency is EUR 80.90
+0.20 (0.25%)
Mar 6, 2026, 11:39 AM CET
BME:ROVI Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,128 | 3,248 | 3,220 | 3,213 | 1,925 | 4,138 | Upgrade
|
| Market Cap Growth | 46.33% | 0.87% | 0.22% | 66.93% | -53.49% | 97.10% | Upgrade
|
| Enterprise Value | 4,162 | 3,333 | 3,340 | 3,223 | 1,902 | 4,066 | Upgrade
|
| Last Close Price | 80.70 | 63.50 | 62.09 | 58.76 | 34.33 | 69.33 | Upgrade
|
| PE Ratio | 29.39 | 23.13 | 23.52 | 18.86 | 9.64 | 27.03 | Upgrade
|
| Forward PE | 26.21 | 21.58 | 19.02 | 19.76 | 12.76 | 25.70 | Upgrade
|
| PS Ratio | 5.55 | 4.37 | 4.22 | 3.87 | 2.35 | 6.38 | Upgrade
|
| PB Ratio | 6.11 | 4.81 | 5.54 | 5.91 | 3.69 | 8.79 | Upgrade
|
| P/TBV Ratio | 6.57 | 5.17 | 5.98 | 6.28 | 3.92 | 9.42 | Upgrade
|
| P/FCF Ratio | 33.87 | 26.65 | 40.68 | 54.04 | 10.30 | 37.89 | Upgrade
|
| P/OCF Ratio | 22.06 | 17.36 | 23.29 | 28.37 | 8.10 | 27.69 | Upgrade
|
| PEG Ratio | 2.27 | 2.31 | 1.73 | 13.17 | 1.42 | 0.84 | Upgrade
|
| EV/Sales Ratio | 5.60 | 4.48 | 4.37 | 3.89 | 2.33 | 6.27 | Upgrade
|
| EV/EBITDA Ratio | 20.61 | 17.05 | 16.73 | 13.54 | 7.01 | 20.69 | Upgrade
|
| EV/EBIT Ratio | 24.03 | 19.25 | 18.69 | 14.69 | 7.50 | 22.57 | Upgrade
|
| EV/FCF Ratio | 34.15 | 27.35 | 42.20 | 54.22 | 10.18 | 37.23 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.18 | 0.20 | 0.12 | 0.14 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 0.60 | 0.60 | 0.56 | 0.27 | 0.26 | 0.36 | Upgrade
|
| Debt / FCF Ratio | 1.00 | 1.00 | 1.45 | 1.10 | 0.39 | 0.67 | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | 0.03 | 0.15 | 0.07 | -0.10 | -0.05 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.12 | 0.12 | 0.43 | 0.17 | -0.19 | -0.13 | Upgrade
|
| Net Debt / FCF Ratio | 0.19 | 0.19 | 1.09 | 0.67 | -0.28 | -0.24 | Upgrade
|
| Asset Turnover | 0.83 | 0.83 | 0.94 | 0.99 | 1.01 | 0.99 | Upgrade
|
| Inventory Turnover | 0.88 | 0.88 | 0.89 | 1.07 | 1.10 | 1.14 | Upgrade
|
| Quick Ratio | 1.51 | 1.51 | 0.99 | 0.83 | 1.04 | 1.35 | Upgrade
|
| Current Ratio | 3.13 | 3.13 | 3.13 | 2.55 | 2.12 | 2.66 | Upgrade
|
| Return on Equity (ROE) | 22.33% | 22.33% | 24.33% | 31.99% | 40.24% | 36.24% | Upgrade
|
| Return on Assets (ROA) | 12.11% | 12.11% | 13.69% | 16.34% | 19.68% | 17.23% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.87% | 19.41% | 22.00% | 32.24% | 43.00% | 35.96% | Upgrade
|
| Return on Capital Employed (ROCE) | 22.40% | 22.40% | 26.50% | 36.60% | 43.40% | 33.20% | Upgrade
|
| Earnings Yield | 3.40% | 4.32% | 4.25% | 5.30% | 10.37% | 3.70% | Upgrade
|
| FCF Yield | 2.95% | 3.75% | 2.46% | 1.85% | 9.71% | 2.64% | Upgrade
|
| Dividend Yield | 1.15% | - | 1.51% | 1.88% | 3.77% | 1.38% | Upgrade
|
| Payout Ratio | 34.06% | 34.06% | 41.24% | 40.54% | 25.55% | 13.80% | Upgrade
|
| Buyback Yield / Dilution | 0.13% | 0.13% | 3.73% | 0.51% | 3.50% | -0.03% | Upgrade
|
| Total Shareholder Return | 1.28% | 0.13% | 5.23% | 2.39% | 7.27% | 1.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.